CHLORPROMAZINE Drug Patent Profile
✉ Email this page to a colleague
When do Chlorpromazine patents expire, and when can generic versions of Chlorpromazine launch?
Chlorpromazine is a drug marketed by Actavis Mid Atlantic, Genus, Pharm Assoc, Rubicon, Wockhardt, Abraxis Pharm, Aspiro, Deva Hlding, Dr Reddys, Eugia Pharma, Gland, Hikma, Marsam Pharms Llc, MSN, Thinq Pharm-cro Pvt, Watson Labs, Wyeth Ayerst, Zydus Pharms, Alpharma Us Pharms, Abbott, Alembic, Amneal Pharms Co, Aurobindo Pharma Ltd, Chartwell Rx, Cycle, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Kv Pharm, Lannett Co Inc, Lederle, Lupin, Purepac Pharm, Pvt Form, Somerset Theraps Llc, Sun Pharm, Teva Pharms, Upsher Smith Labs, Vangard, West Ward, Zameer Pharms, and Zydus Lifesciences. and is included in seventy-five NDAs.
The generic ingredient in CHLORPROMAZINE is chlorpromazine hydrochloride. There are twenty-four drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlorpromazine
A generic version of CHLORPROMAZINE was approved as chlorpromazine hydrochloride by ZYDUS LIFESCIENCES on January 17th, 2020.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CHLORPROMAZINE?
- What are the global sales for CHLORPROMAZINE?
- What is Average Wholesale Price for CHLORPROMAZINE?
Summary for CHLORPROMAZINE
| US Patents: | 0 |
| Applicants: | 41 |
| NDAs: | 75 |
| Drug Prices: | Drug price information for CHLORPROMAZINE |
| DailyMed Link: | CHLORPROMAZINE at DailyMed |
Recent Clinical Trials for CHLORPROMAZINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ji Xunming,MD,PhD | NA |
| University Hospital, Strasbourg, France | PHASE2 |
| Capital Medical University | PHASE1 |
Medical Subject Heading (MeSH) Categories for CHLORPROMAZINE
Anatomical Therapeutic Chemical (ATC) Classes for CHLORPROMAZINE
US Patents and Regulatory Information for CHLORPROMAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 212996-004 | Jan 22, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sun Pharm | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 214256-001 | Oct 26, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma Ltd | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 216788-003 | Apr 25, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Alembic | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 217350-004 | Jul 18, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
